期刊文献+

血清miR-340-5p检测在肺癌诊治中的临床价值研究 被引量:1

Clinical value of serum miR-340-5p detection in the diagnosis and treatment of lung cancer
原文传递
导出
摘要 目的通过检测微小miR-340-5p在肺癌患者血清中的表达,研究其与肺癌患者临床病理特征的相关性,并探讨其能否作为肺癌早期诊断的潜在肿瘤标志物的可能性。方法应用逆转录定量聚合酶链反应(RT-q PCR)分析法对55例肺癌患者、21例健康者、32例肺部良性疾病患者血清中的miR-340-5p水平进行检测,采用方差方程的Levene检验及均值方程的t检验进行统计学比较。用ROC曲线对指标的诊断效能进行分析和评价。结果肺癌患者组血清中的miR-340-5p肿瘤标志物水平明显高于健康组和肺部良性疾病患者组,FC值为6.48,差异有统计学意义(F=12.23,P<0.05;t=-4.44,df=83.8,P<0.05)。ROC曲线下面积AUC为0.785,灵敏度为66.3%,特异度为73.7%。结论 miR-340-5p在肿瘤患者中是高表达,在血清中的检测对肺癌的诊断有一定的临床价值,并有较高的灵敏度和特异度,是诊断肺癌较为理想的指标。 Objective Through the detection of micro miR-340-5p expression in the serum of patients with lung cancer and its correlation with clinicopathological characteristics of patients,so as to explore the possibility of its potential as a potential tumor marker for the early diagnosis of lung cancer.Methods RT-q PCR analysis was used to detect 55 lung cancer patients and 21 healthy people,32 patients with benign lung disease in serum miR-340-5p levels; statistical comparison t test was performed using Levene test and variance equation of the mean equation.Analysis and evaluation of the diagnostic efficacy of indexes were performed by ROC curve.Results The sign level of the serum of lung cancer patients in the miR-340-5p group was significantly higher than that of tumor markers of patients with benign disease in healthy group and lung group,and the difference was statistically significant(F = 12.23,P〈0.05; t =-4.44,df = 83.8,P〈0.05).FC value was 6.48.ROC area under the AUC curve was 0.785,the sensitivity was 66.3%,and the specificity was 73.7%.Conclusion miR-340-5p is highly expressed in tumor patients,the detection of serum in the diagnosis of lung cancer has a certain clinical value,and has a high sensitivity and specificity,is an ideal indicator for the diagnosis of lung cancer.
作者 黄江浩 朱兆均 刘平 叶佐婉 於艳霞 熊远香 HUANG Jiang-hao ZHU Zhao-jun LIU Ping YE Zuo-wan YU Yan-xia XIONG Yuan-xiang(Shajing Hospital Affiliated to Guangzhou Medical University, Shenzhen, Guangdong 518104, China)
出处 《中国卫生检验杂志》 CAS 2017年第4期508-510,共3页 Chinese Journal of Health Laboratory Technology
基金 深圳市宝安区科技创新局医疗卫生科研项目立项(2014182)
关键词 肺肿瘤 miR-340-5p 逆转录定量聚合酶链反应技术测定 Lung neoplasms miR-340-5p RT-qPCR technique
  • 相关文献

参考文献4

二级参考文献33

  • 1谢新立,赵文增,刘保平,韩星敏,杜晓光,郭鹏德.^(99)Tc^m-HL91肺癌显像的临床应用[J].中华核医学杂志,2003,23(6):359-360. 被引量:30
  • 2廖永德,赵金平,周晟,付圣灵,万燕青,Mayer Doris.IGF1和IGF2表达与非小细胞肺癌淋巴结转移的相关性[J].肿瘤防治研究,2006,33(12):868-871. 被引量:9
  • 3Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 4Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 5Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 6Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 7Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 8Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 9Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 10Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.

共引文献992

同被引文献9

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部